- Supported exchanges /
- IS /
- GENIL.IS
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL IS) stock market data APIs
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration and licensing agreement with Sulfateq BV for the development and commercialization of the original molecule SUL-238 as a unique treatment for Alzheimer's disease and other neurodegenerative diseases. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Financial Data Overview
| 105.6 | |
| 103.9 | |
| - | |
| 105.6 | |
| 102.7 | |
| 42.1436-105.6 | |
| 31 680 M | |
| 42.4096 | |
| 300 M | |
| 10 920 M | |
| 0.3726 | |
| 0.0083 | |
| 1.2 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Fundamental Data is available in our Financial Data APIs
- Net Revenue 10 920 M
- EBITDA 1 311 M
- Earnings Per Share 2.49
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
